Infinium Pharmachem share news, announcements and annual reports
NSE: INFINIUMPharmaceuticals & Biotechnology
Share price at the NSE close on 30 Oct 2026. Previous close ₹278.00.
30 Oct: open ₹285.75, high ₹285.75, low ₹281.00
- Next results date: the board meets on 6 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹438 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 36.04
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.62
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,500100.0% delivered
Infinium Pharmachem has 128 announcements on record, routine notices left out; 2 in the 30 days to 30 Oct 2026, the latest on 27 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Infinium Pharmachem half-yearly results
The board meets on 6 Nov 2026 to consider financial results
Notice filed 27 Oct 2026
To consider and approve the half year financial results for the period ended September 30, 2026
Infinium Pharmachem annual reports, presentations and earnings calls
The company's own documents, latest first.Infinium Pharmachem financials, year by year
Annual reports4
- Annual report, year to Mar 202622 Aug 2026
- Annual report, year to Mar 202528 Aug 2025
- Annual report, year to Mar 20246 Sep 2024
- Annual report, year to Mar 20232 Aug 2023, a zip file
Investor presentations3
- Investor Presentation24 Nov 2025
- Presentation9 Jun 2024
- Presentation29 Feb 2024
Earnings calls4
- Transcript15 Jun 2024
- Link of Recording10 Jun 2024
- Transcript13 Mar 2024
- Link of Recording8 Mar 2024
Infinium Pharmachem share news and announcements
Newest first. Page 1 of 3.
Oct 2026
Sep 2026
22 Sep · Rating
17 Sep · Meeting
Aug 2026
27 Aug · Analysts
26 Aug · Corporate action
25 Aug · Meeting
22 Aug · Management
22 Aug · Board meeting
14 Aug · Board meeting
Jun 2026
23 Jun · Updates
May 2026
29 May · Results
Apr 2026
Mar 2026
13 Mar · Change in Company Secretary/Compliance Officer
13 Mar · Board meeting
3 Mar · Board meeting
Feb 2026
23 Feb · Disruption of Operations
Jan 2026
Nov 2025
19 Nov · Analysts
13 Nov · Board meeting
13 Nov · Board meeting
Sep 2025
25 Sep · Meeting
25 Sep · Meeting
10 Sep · Corporate action
Aug 2025
21 Aug · Board meeting
13 Aug · Board meeting
Jul 2025
Jun 2025
26 Jun · Business
May 2025
28 May · Board meeting
10 May · Board meeting
Not held on this date
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 22 Sep 2026Credit ratingdown 4.48%−4.2 pts vs Nifty 500market median 0.0% · five sessions −2.2% (+0.6 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 29 May 2026Resultsup 0.35%+1.7 pts vs Nifty 500market median −0.7% · five sessions −1.4% (+0.7 pts vs Nifty 500) · volume 1.7× usual · The announcement
- 2 Apr 2026Board or managers changedup 1.98%+2.0 pts vs Nifty 500market median 0.0% · five sessions +8.9% (+3.6 pts vs Nifty 500) · volume 2.1× usual · The announcement
- 11 Jan 2024Credit ratingup 0.47%+0.1 pts vs Nifty 500market median 0.0% · five sessions +5.4% (+5.5 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 18 Oct 2023Board or managers changedup 1.42%+2.1 pts vs Nifty 500market median 0.0% · five sessions −2.5% (+1.6 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 17 May 2023Resultsup 4.76%+5.2 pts vs Nifty 500market median −0.7% · five sessions +13.9% (+13.6 pts vs Nifty 500) · volume 0.8× usual · The announcement
Infinium Pharmachem results filing dates and deadlines
Listed companies must file half-yearly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.